Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.6B |
| 2 |
Broadcom
AVGO
|
+$1.11B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$882M |
| 4 |
JPMorgan Chase
JPM
|
+$628M |
| 5 |
Tesla
TSLA
|
+$594M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.54B |
| 2 |
Visa
V
|
+$1.39B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.13B |
| 4 |
Amazon
AMZN
|
+$771M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$575M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.83% |
| 2 | Financials | 7.37% |
| 3 | Consumer Discretionary | 6.6% |
| 4 | Communication Services | 5.05% |
| 5 | Healthcare | 4.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3326
PUT
Avantor
AVTR
$9.37B
| $942K | ﹤0.01% |
+70,000
| New | +$958K |
|
3327
Axogen
AXGN
$2.67B
| $940K | ﹤0.01% |
86,665
+21,913
| +34% | +$287K |
|
3328
Elbit Systems
ESLT
$36.5B
| $939K | ﹤0.01% |
+2,090
| New | +$848K |
|
3329
CALL
Baker Hughes
BKR
$63B
| $939K | ﹤0.01% |
+24,500
| New | +$925K |
|
3330
Greene County Bancorp
GCBC
$601M
| $937K | ﹤0.01% |
42,188
+29,697
| +238% | +$658K |
|
|
HOUS
3331
DELISTED
Anywhere Real Estate
HOUS
| $936K | ﹤0.01% |
258,524
+90,872
| +54% | +$317K |
|
3332
Orthofix Medical
OFIX
$415M
| $936K | ﹤0.01% |
83,913
-19,421
| -19% | -$241K |
|
3333
PUT
Capricor Therapeutics
CAPR
$244M
| $934K | ﹤0.01% |
+94,100
| New | +$994K |
|
3334
Nature's Sunshine
NATR
$273M
| $932K | ﹤0.01% |
63,041
+26,851
| +74% | +$363K |
|
|
CTO
3335
CTO Realty Growth
CTO
$819M
| $932K | ﹤0.01% |
53,990
-4,157
| -7% | -$75.2K |
|
3336
Aveanna Healthcare
AVAH
$2.46B
| $931K | ﹤0.01% |
177,993
+62,450
| +54% | +$317K |
|
3337
The RealReal
REAL
$1.36B
| $927K | ﹤0.01% |
193,519
+68,842
| +55% | +$379K |
|
3338
Thryv Holdings
THRY
$96.9M
| $926K | ﹤0.01% |
76,151
+20,098
| +36% | +$260K |
|
3339
Humacyte
HUMA
$148M
| $926K | ﹤0.01% |
442,979
+248,350
| +128% | +$477K |
|
|
TSSI
3340
TSS Inc
TSSI
$336M
| $926K | ﹤0.01% |
+32,110
| New | +$422K |
|
3341
CALL
Ollie's Bargain Outlet
OLLI
$4.73B
| $922K | ﹤0.01% |
+7,000
| New | +$801K |
|
3342
Personalis
PSNL
$1.54B
| $921K | ﹤0.01% |
140,378
+54,387
| +63% | +$252K |
|
3343
iShares MSCI China ETF
MCHI
$6.14B
| $921K | ﹤0.01% |
16,711
-16,613
| -50% | -$882K |
|
3344
Zevra Therapeutics
ZVRA
$679M
| $919K | ﹤0.01% |
104,351
-330,339
| -76% | -$2.68M |
|
|
ILPT
3345
Industrial Logistics Properties Trust
ILPT
$605M
| $919K | ﹤0.01% |
201,958
-37,876
| -16% | -$125K |
|
|
TERN
3346
DELISTED
Terns Pharmaceuticals
TERN
| $912K | ﹤0.01% |
244,637
-408,400
| -63% | -$1.28M |
|
|
SAGE
3347
DELISTED
Sage Therapeutics
SAGE
| $909K | ﹤0.01% |
99,618
+40,031
| +67% | +$294K |
|
3348
Graham Corp
GHM
$1.33B
| $906K | ﹤0.01% |
18,308
+6,222
| +51% | +$231K |
|
3349
The RMR Group
RMR
$337M
| $906K | ﹤0.01% |
55,413
+9,984
| +22% | +$153K |
|
|
FPI
3350
Farmland Partners
FPI
$425M
| $906K | ﹤0.01% |
78,709
+20,281
| +35% | +$217K |
|
Similar funds
Barclays's Q2 2025 Portfolio in Review
As of Q2 2025, Barclays held 5,681 positions worth $436B, up 24% from $353B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Barclays deployed $35.4B of net new capital in Q2 2025, opening 461 new positions and adding to 2,914 existing holdings. Its largest new stake was iShares MBS ETF: 4,310,047 shares worth $405M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Honeywell, an estimated $1.54B trimmed.
- Barclays's largest Q2 2025 buy was iShares MBS ETF: 4,310,047 shares worth $405M.
- Barclays added most to NVIDIA in Q2 2025, an estimated $1.6B increase.
- Barclays's biggest Q2 2025 reduction was Honeywell, cutting an estimated $1.54B.
- Barclays fully exited Berry Global Group, Inc. in Q2 2025, selling an estimated $173M.
- Barclays's ten largest holdings make up 43% of its $436B portfolio in Q2 2025.
- Barclays opened 461 new positions and closed 463 in Q2 2025.
- Barclays's portfolio value rose 24% quarter-over-quarter to $436B.
Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.